Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
There is an urgent need for effective therapies against the novel COVID-19 virus. Studies have shown that amiodarone and verapamil can interfere with coronavirus entry and amplification by blocking ion channels. ReCOVery-SIRIO is a randomized study to investigate amiodarone or verapamil compared with usual care in symptomatic patients hospitalized with confirmed COVID-19 infection.
Epistemonikos ID: 232b2dc236cb76fb4c570057d00ff3a26e295e64
First added on: Apr 18, 2020